Dr. Silke Viaene
ActiveSummary
Dr. Silke Viaene has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €240k and a net result of €135k. Its solvency ranks better than 55% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
97
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency93▲+7
Growth78
Track record82
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €23k at 30 days only on tighter terms
Liquidity ample (current ratio 15.59 against 12.41 in 2024; short-term debt: 6.2% and cash: 53.1% of total assets), and 31.8% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
68.2%
Return on assets
38.4%
Age of the figures
12 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 30-04-2026, 0 days ahead of the deadline.
NBB · 2 filingsDeviation from the deadline
2025
on the day
2024
1 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today30-09-2026 close30-04-2027 deadline
Financials · fiscal year 2025, micro schema
Source amounts without an identifiable currency are assumed to be EUR.
Equity
€240k▲ 127%
2024 · €106k
2024: €106k
2024 → 2025
Total assets
€352k▲ 103%
2024 · €173k
2024: €173k
2024 → 2025
Net result
€135k▲ 33.0%
2024 · €102k
2024: €102k
2024 → 2025
Working capital
€320k▲ 104%
2024 · €157k
2024: €157k
2024 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20242025Trend
Equity€106k-€240k▲ 127%
Operating result€130k-€176k▲ 35.1%
Net result€102k-€135k▲ 33.0%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result rises in 2025; 2025 is 35% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €352k
Fixed assets
€10k ▲ 255%
Current assets
€342k ▲ 101%
Equity and liabilities €352k
Equity
€240k ▲ 127%
Debt
€112k ▲ 66.0%
Debt's share of the balance-sheet total falls from 38.9% to 31.8%. Equity and debt are higher.
Key figures and ratios
EBITDA
€180k▲
2024 · €137k
Cash flow
€139k▲
2024 · €108k
Current ratio
15.59▲
2024 · 12.41
Debt to equity
0.47▼
2024 · 0.64
ROE
56.3%▼
2024 · 96.1%
ROA
38.4%▼
2024 · 58.7%
Interest coverage
530.41▼
2024 · 1430.03
Debt ≤ 1 year
€22k▲
2024 · €14k
Debt > 1 year
€18k▼
2024 · €27k
Income taxes
€41k▲
2024 · €29k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 41 lines
Balance sheet
Code20242025
Assets
Total assets20/58€173k€352k▲
Fixed assets21/28€3k€10k▲
Tangible fixed assets22/27€3k€10k▲
Plant, machinery and equipment23€3k€10k▲
Current assets29/58€170k€342k▲
Amounts receivable within one year40/41€88k€145k▲
Trade receivables40€87k€145k▲
Other amounts receivable41€1k-
Cash at bank and in hand54/58€62k€187k▲
Deferred charges and accrued income490/1€20k€10k▼
Equity and liabilities
Total equity and liabilities10/49€173k€352k▲
Equity10/15€106k€240k▲
Contributions10/11€5k€5k=
Reserves13€101k€235k▲
Distributable reserves133€101k€235k▲
Amounts payable17/49€67k€112k▲
Amounts payable after more than one year17€27k€18k▼
Financial debts170/4€27k€18k▼
Amounts payable within one year42/48€14k€22k▲
Current portion of amounts payable after more than one year42€8k€9k▲
Trade debts44€3k€231▼
Suppliers440/4€3k€231▼
Taxes, remuneration and social security45-€11k
Taxes450/3-€11k
Other amounts payable47/48€2k€2k▼
Accrued charges and deferred income492/3€27k€72k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€7k€3k▼
Other operating charges640/8€395€291▼
Gross operating margin9900€137k€180k▲
Operating profit (loss)9901€130k€176k▲
Financial charges65/66B€96€338▲
Recurring financial charges65€96€338▲
Profit (loss) for the period before taxes9903€130k€176k▲
Income taxes67/77€29k€41k▲
Profit (loss) for the period9904€102k€135k▲
Profit (loss) for the period to be appropriated9905€102k€135k▲
Appropriation of the result
Profit (loss) to be appropriated9906€102k€135k▲
Transfer to equity691/2€101k€134k▲
To other reserves6921€101k€134k▲
Profit to be distributed694/7€833€833=
Return on contributions (dividend)694€833€833=
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-04
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-09
Financial
Equity above €200kEq €240k ▲127%
2 profitable years in a row build equity to €240k.
29-04
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hooglede · 1 establishment unit since 2023
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Schoolstraat 78830 HoogledeGround area
108 m²
Building footprint
108 m²
Volume, LiDAR
819 m³
Parcel 36006D1349/00V003, Flanders · tallest building 11.2 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Dr. Silke Viaene
since 20232.350.178.950
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 36006D1349/00V003 | Flanders | 108 m² | 1 · 108 m² | 11.2 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DOCTEUR HOUSE
BE 0895.761.346
Ath · Eq €240,245
DOKTER LIESBETH STOKMAN
BE 0791.485.455
Kapellen · Eq €240,033
MED ZENGIN
BE 0690.634.654
Braine-l'Alleud · Eq €239,953
Pattyn Nele Huisarts
BE 0757.574.453
Ieper · Eq €240,513
Docteur BEN JABALLAH
BE 0818.182.132
Verviers · Eq €239,824
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 5,318 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded28-09-2023
Fiscal year end30-09
Activities, NACEBEL 2025
86210General medical practice
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 2 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.